HEMORRHAGIC SHOCK & ENCEPHALOPATHY SYNDROME - HSES

Hemorrhagic shock and encephalopathy syndrome is an extremely rare disease characterized by acute onset of severe shock, coagulopathy, encephalopathy, and hepatic and renal dysfunction in previously healthy children, resulting in death or catastrophic neurologic outcome.

Hemorrhagic shock and encephalopathy syndrome (HSES) occurs predominantly in infants aged 3 to 8 mo (median age, 5 mo) but was reported in a 15-yr-old. HSES resembles heatstroke, with extremely high temperature and multiple organ dysfunction, but the cause is unknown. Overwrapping of infants who have febrile illness has been suggested, but evidence is slim. Other theories include a reaction to intestinal or environmental toxins, pancreatic release of trypsin, or an unidentified virus or bacterium. Diffuse cerebral edema with herniation and focal hemorrhages and infarcts in the cerebral cortex and other organs are common. The lungs and myocardium are not primarily involved.

Symptoms and Signs

A prodrome of fever, upper respiratory tract symptoms, or vomiting and diarrhea occurs in most patients. The major features are an acute onset of encephalopathy, cerebral edema (manifested as seizures, coma, and hypotonia), and severe shock (ie, hypotension and poor perfusion). Other common features include hyperpyrexia (up to 43.9° C rectally), bloody or watery diarrhea, disseminated intravascular coagulation (DIC), myoglobinuria, and rhabdomyolysis.

Diagnosis

Similar symptoms can result from sepsis, Reye's syndrome, and hemolytic-uremic syndrome. Patients require laboratory evaluation including blood and urine culture, ABG, CBC, electrolytes, BUN, creatinine, PT/PTT, and liver function tests. Multiple abnormalities include metabolic acidosis, elevated liver transaminases, acute renal failure, thrombocytopenia, falling Hct, leukocytosis, hypoglycemia, and hyperkalemia. Bacteriologic and viral cultures are negative. Diagnosis is by exclusion.

Prognosis and Treatment

In all series, > 60% of patients died, and 70% of survivors had severe neurologic sequelae.

Treatment is entirely supportive. Infusions of large volumes of isotonic solutions and blood products (fresh frozen plasma, albumin, whole blood, packed RBCs) along with inotropic support - eg, dopamine (INTROPIN), epinephrine) are necessary to maintain circulation. Marked temperature elevation (eg, > 39° C) requires external cooling (see Heat Illness: Prognosis and Treatment). Increased intracranial pressure from cerebral edema requires intubation and hyperventilation. DIC often progresses despite use of fresh frozen plasma.

Courtesy: The Merck Manuals